PACLITAXEL EBEWE

Concentrate for solution for infusion, 100mg/16.7ml
RxActive license

Active substance (INN)

paclitaxel

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength100mg/16.7ml
PackagingUkupno 1 bočica staklena sa 16.7ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerFareva Unterach GmbH, Austria
Therapeutic groupAntineoplastic and immunomodulating agents (L01CD01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJanuary 24, 2020

Analogs in Montenegro

8

Other medicines with the same active substance

ABRAXANERx
Powder for dispersion for infusion, 5mg/mlCelgene Distribution B.V.
PACLITAXEL EBEWERx
Concentrate for solution for infusion, 30mg/5mlFareva Unterach GmbH
PACLITAXELUM ACCORDRx
Concentrate for solution for infusion, 6mg/mlAccord Healthcare Polska Sp. z o.o.
PACLITAXELUM ACCORDRestricted
Concentrate for solution for infusion, 6mg/mlAccord Healthcare Polska Sp. z o.o.
PATAXELRx
Concentrate for solution for infusion, 100mg/16.7mlVianex S.A. - Plant C
PATAXELRestricted
Concentrate for solution for infusion, 30mg/5mlVianex S.A. - Plant C
SINDAXEL®Rx
Concentrate for solution for infusion, 30mg/5mlS. C. Sindan-Pharma S.r.l.
SINDAXEL®Rx
Concentrate for solution for infusion, 100mg/16.67mlS. C. Sindan-Pharma S.r.l.
Source: CInMED register